In an effort to increase effectiveness and simplicity in sale methods in initial public offerings (“IPOs”), the Turkish securities regulator (CMB) has recently resolved that certain sized IPOs not to be sold with or without book building method but only through sale on the exchange method (Borsa’da satış). The decision is published and is effective as of 19 January 2023. As per the CMB decision, this method has become mandatory for IPOs, in case the market value of the shares to be offered to the public is TRY 250 million or less.
We have published a new Paksoy briefing: “Recent Decisions in Turkish Capital Markets”. You can reach the briefing here.
Share
Related persons
You can contact us for detailed information.




Legal Information
This briefing is for information purposes; it is not legal advice. If you have questions, please call us. All rights reserved.
You May Be Interested In
24 April 2026
Turkish competition board fines seventeen pharmaceutical companies for no-poach agreements and wage data exchange
On 8 April 2026, the Turkish Competition Board published its decision dated 11 September 2025 and numbered 25-34/810-474 concluding a broad…
22 April 2026
Fintech in Türkiye 2026 – law and practice
The fintech sector in Türkiye has been developing steadily over the past several years, with growth accelerating significantly in recent…
22 April 2026
Fintech in Türkiye 2026 – trends and developments
The fintech sector in Türkiye has been developing steadily over the past several years, with growth accelerating significantly in recent…
20 April 2026
Bill on digital copyright and online news content
Following the submission of the Digital Copyright Bill (“Digital Copyright Bill“) to the Presidency of the Grand National Assembly of…
15 April 2026
Just cause termination in disciplinary investigations under Turkish law
Heightened regulatory expectations and evolving corporate governance standards have placed internal investigations at the centre of…
13 April 2026
Recent developments in healthcare legislation – Issue 2026/1
The Guideline on Trust Practices in Clinical Trial Applications published by the Turkish Medicines and Medical Devices Agency was updated…